Oakville, Ontario--(Newsfile Corp. - October 25, 2021) - Cardiol Therapeutics Inc.(NASDAQ: CRDL)(TSX: CRDL)("Cardiol" or the "Company"), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, is pleased to announce that it has received approval from Health...